2026 Abstract Submissions

MIN 2026 welcomes delegate submissions for the opportunity to present your work in the symposium program.

Abstract Submissions close FRIDAY 14 AUGUST 2026.

SUBMISSIONS OPEN NOW

 
 
 

Program Topics

The following topics will be covered for both oral and poster presentations:

  • Autoimmune Diseases

  • Cancer Immunotherapy

  • Chronic Inflammatory Diseases

  • Diagnostics/New Tech

  • Infectious Diseases

  • mRNA-Based Therapeutics

 

Why should I submit?

Peer-to-peer learning is a great way to fill knowledge gaps. MIN delegates are very experienced and knowledgeable, however, there is always room to learn.

We encourage you to share your own experiences, expertise and research with peers.

Not only will this help others learn, presenting at a conference is a great way to further your own development, make connections and extend the reach of your work.

What types of presentations are available?

MIN 2026 offers both oral and poster presentations. The program committee will review all abstract submissions and allocate submissions to the program based on topic and quality.

Please note: we cannot guarantee all submission preferences (i.e. oral presentations) will be met. While we strive to fulfill all preferences, limited speaking opportunities are available. Some requests for talks may need to be allocated poster presentations. We thank you for your understanding.

Abstract Format

Abstracts are limited to 300 words or less. This does not include your title.

Please ensure your abstract follows the below format:

  • an introductory statement that outlines the background and significance of the study

  • a succinct description of the basic methodologies

  • a clear indication of the major findings of the study

  • a concluding statement